NM_000350.3:c.6006-16G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000350.3(ABCA4):​c.6006-16G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.172 in 1,610,232 control chromosomes in the GnomAD database, including 24,726 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.17 ( 2111 hom., cov: 32)
Exomes 𝑓: 0.17 ( 22615 hom. )

Consequence

ABCA4
NM_000350.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12O:2

Conservation

PhyloP100: -1.53

Publications

11 publications found
Variant links:
Genes affected
ABCA4 (HGNC:34): (ATP binding cassette subfamily A member 4) The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ABC1 subfamily. Members of the ABC1 subfamily comprise the only major ABC subfamily found exclusively in multicellular eukaryotes. This protein is a retina-specific ABC transporter with N-retinylidene-PE as a substrate. It is expressed exclusively in retina photoreceptor cells, and the gene product mediates transport of an essental molecule, all-trans-retinal aldehyde (atRAL), across the photoreceptor cell membrane. Mutations in this gene are found in patients diagnosed with Stargardt disease, a form of juvenile-onset macular degeneration. Mutations in this gene are also associated with retinitis pigmentosa-19, cone-rod dystrophy type 3, early-onset severe retinal dystrophy, fundus flavimaculatus, and macular degeneration age-related 2. [provided by RefSeq, Sep 2019]
ABCA4 Gene-Disease associations (from GenCC):
  • ABCA4-related retinopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • cone-rod dystrophy 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • severe early-childhood-onset retinal dystrophy
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • retinitis pigmentosa 19
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • cone-rod dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Stargardt disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 1-94005598-C-T is Benign according to our data. Variant chr1-94005598-C-T is described in ClinVar as Benign. ClinVar VariationId is 99426.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.18 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ABCA4NM_000350.3 linkc.6006-16G>A intron_variant Intron 43 of 49 ENST00000370225.4 NP_000341.2
ABCA4NM_001425324.1 linkc.5784-16G>A intron_variant Intron 42 of 48 NP_001412253.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ABCA4ENST00000370225.4 linkc.6006-16G>A intron_variant Intron 43 of 49 1 NM_000350.3 ENSP00000359245.3
ABCA4ENST00000465352.1 linkn.422-16G>A intron_variant Intron 4 of 5 5
ABCA4ENST00000484388.1 linkn.120-16G>A intron_variant Intron 1 of 1 2

Frequencies

GnomAD3 genomes
AF:
0.166
AC:
25169
AN:
151916
Hom.:
2107
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.156
Gnomad AMI
AF:
0.136
Gnomad AMR
AF:
0.128
Gnomad ASJ
AF:
0.205
Gnomad EAS
AF:
0.130
Gnomad SAS
AF:
0.127
Gnomad FIN
AF:
0.172
Gnomad MID
AF:
0.108
Gnomad NFE
AF:
0.183
Gnomad OTH
AF:
0.156
GnomAD2 exomes
AF:
0.157
AC:
39376
AN:
250816
AF XY:
0.158
show subpopulations
Gnomad AFR exome
AF:
0.157
Gnomad AMR exome
AF:
0.0941
Gnomad ASJ exome
AF:
0.198
Gnomad EAS exome
AF:
0.127
Gnomad FIN exome
AF:
0.173
Gnomad NFE exome
AF:
0.181
Gnomad OTH exome
AF:
0.163
GnomAD4 exome
AF:
0.173
AC:
251558
AN:
1458196
Hom.:
22615
Cov.:
33
AF XY:
0.172
AC XY:
124563
AN XY:
725516
show subpopulations
African (AFR)
AF:
0.161
AC:
5385
AN:
33398
American (AMR)
AF:
0.100
AC:
4477
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.199
AC:
5193
AN:
26102
East Asian (EAS)
AF:
0.135
AC:
5371
AN:
39680
South Asian (SAS)
AF:
0.131
AC:
11308
AN:
86188
European-Finnish (FIN)
AF:
0.175
AC:
9321
AN:
53278
Middle Eastern (MID)
AF:
0.142
AC:
821
AN:
5764
European-Non Finnish (NFE)
AF:
0.180
AC:
199696
AN:
1108794
Other (OTH)
AF:
0.166
AC:
9986
AN:
60286
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
9611
19222
28832
38443
48054
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6918
13836
20754
27672
34590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.166
AC:
25203
AN:
152036
Hom.:
2111
Cov.:
32
AF XY:
0.163
AC XY:
12136
AN XY:
74300
show subpopulations
African (AFR)
AF:
0.156
AC:
6484
AN:
41456
American (AMR)
AF:
0.128
AC:
1958
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.205
AC:
712
AN:
3470
East Asian (EAS)
AF:
0.130
AC:
675
AN:
5174
South Asian (SAS)
AF:
0.128
AC:
615
AN:
4822
European-Finnish (FIN)
AF:
0.172
AC:
1818
AN:
10550
Middle Eastern (MID)
AF:
0.102
AC:
30
AN:
294
European-Non Finnish (NFE)
AF:
0.183
AC:
12450
AN:
67964
Other (OTH)
AF:
0.160
AC:
337
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1057
2113
3170
4226
5283
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
282
564
846
1128
1410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.170
Hom.:
4013
Bravo
AF:
0.162
Asia WGS
AF:
0.133
AC:
462
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:12Other:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Jan 23, 2017
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Oct 10, 2012
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2Other:2
-
Retina International
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
GenomeConnect, ClinGen
Significance:not provided
Review Status:no classification provided
Collection Method:phenotyping only

GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -

Age related macular degeneration 2 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Severe early-childhood-onset retinal dystrophy Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Retinitis pigmentosa 19 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cone-rod dystrophy 3 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
3.5
DANN
Benign
0.59
PhyloP100
-1.5
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4147863; hg19: chr1-94471154; COSMIC: COSV64672003; API